Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P35680: Variant p.Lys164Gln

Hepatocyte nuclear factor 1-beta
Gene: HNF1B
Feedback?
Variant information Variant position: help 164 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Lysine (K) to Glutamine (Q) at position 164 (K164Q, p.Lys164Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (K) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In RCAD. Any additional useful information about the variant.


Sequence information Variant position: help 164 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 557 The length of the canonical sequence.
Location on the sequence: help GLNQSHLSQHLNKGTPMKTQ K RAALYTWYVRKQREILRQFN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 557 Hepatocyte nuclear factor 1-beta
Domain 93 – 188 POU-specific atypical
Helix 162 – 181



Literature citations
Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations.
Bellanne-Chantelot C.; Chauveau D.; Gautier J.-F.; Dubois-Laforgue D.; Clauin S.; Beaufils S.; Wilhelm J.-M.; Boitard C.; Noeel L.-H.; Velho G.; Timsit J.;
Ann. Intern. Med. 140:510-517(2004)
Cited for: VARIANTS RCAD PRO-112; GLU-136; GLN-164; HIS-165 AND HIS-295; Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5.
Bellanne-Chantelot C.; Clauin S.; Chauveau D.; Collin P.; Daumont M.; Douillard C.; Dubois-Laforgue D.; Dusselier L.; Gautier J.-F.; Jadoul M.; Laloi-Michelin M.; Jacquesson L.; Larger E.; Louis J.; Nicolino M.; Subra J.-F.; Wilhem J.-M.; Young J.; Velho G.; Timsit J.;
Diabetes 54:3126-3132(2005)
Cited for: VARIANTS RCAD CYS-76; PRO-112; GLU-136; GLN-164; HIS-165; GLN-235; GLY-276; ASP-285; CYS-295; HIS-295 AND SER-370;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.